Answers are grounded in this paper and cite their sources.
Thermal inactivation of Salmonella enterica (8-strain cocktail) was evaluated in three lipid-based nutrient supplement (LNS) formulations with low water activity (0.30 - 0.34): peanut-based (PB), chickpea-based (CP), and a high-fat/high-sugar worst-case (WC) matrix made using the PB product. Inoculated samples were subjected to controlled thermal treatments from 87 to 115 °C, for 5 to 1200 s depending on temperature, and kinetic parameters for Salmonella inactivation were determined. Across products, inactivation followed a log-linear behavior, with R² > 0.90 for most primary-model fits. CP exhibited the highest z-value (22.1 °C), followed by WC (19.2 °C) and PB (17.8 °C). Pairwise analysis confirmed that CP and PB differed significantly in z-value ( p < 0.05), indicating that incremental temperature increases are less effective in the CP formulation. These results show that Salmonella thermal resistance in these three LNS is formulation-dependent, and that processing conditions validated in one LNS cannot be generalized to others. Given the targeted population for LNS distribution, procurement specifications may require manufacturers to demonstrate validated processes capable of achieving ≥5-log reduction of Salmonella to ensure an adequate safety margin. This study provides product-specific kinetic data and underscores the need for independent validation of lethality steps in different LNS formulations.
No takes yet. Share an insight, caveat, or question.
Çobo et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: